icometrix
6
2
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
Role: collaborator
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Role: lead
Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study
Role: lead
Remote MS Care in Antwerp
Role: collaborator
CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis
Role: lead
CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI
Role: collaborator
All 6 trials loaded